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Abstract The transcription factor c-Myc is a substrate for phosphorylation by MAP kinases. Here we demonstrate that MAP kinase binds to c-Myc. 
The NH2-terminal region (residues 1-100) is necessary and sufficient for this interaction. Binding to c-Myc is not dependent on the state of MAP 
kinase activation. However, the c-Myc/MAP kinase complex is disrupted by ATE Together, these observations indicate that substrate binding 
interactions contribute to the specificity of phosphorylation by MAP kinases. 
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1. Introduction 2. Materials and methods 
We have recently identified a novel family of human protein 
kinases, JNKs (also designated SAPKs [1]), that are activated 
by dual phosphorylation at Thr and Tyr within sub-domain 
VIII [2]. The mechanism of JNK activation by dual phospho- 
rylation is similar to that reported for the ERK sub-family of 
MAP kinases [3,4]. However, the signal transduction pathways 
that lead to J'NK and ERK activation are distinct [2]. Thus, 
there are at least wo MAP kinase signal transduction pathways 
in mammalian cells. 
A distinctive property of JNK protein kinases is the high 
level of substrate specificity of these enzymes. The only JNK 
substrate that has been identified is the transcription factor 
c-Jun [1,2,5,6]. This high level of substrate specificity is medi- 
ated by the binding of JNK to the ~ sub-region of the transac- 
tivation domain of c-Jun [2,5,6]. Interestingly, the d~ sub-region 
of v-Jun contains a deletion and it has been demonstrated that 
this mutation accounts for the failure of JNK protein kinases 
to bind and phosphorylate v-Jun [2,5,6]. Together, these data 
indicate that JNK protein kinases bind and phosphorylate spe- 
cific substrates. ERKs, like JNKs, also exhibit a high level of 
substrate specificity [7-9]. It has been established that ERKs 
bind to NGF receptors [10,11], the protein kinase p90 r'k [12,13], 
and the MAP kinase phosphatases 3CH 134 and PAC-1 [14,15]. 
However, the role of these binding interactions i  poorly under- 
stood. 
The purpose of the studies described in this report was to 
investigate the interactions of ERK MAP kinases with sub- 
strates. We have previously demonstrated that ERK phospho- 
rylates the transcription factor c-Myc at Ser-62 [7]. Here, we 
show that ERK binds to the NH2-terminal activation domain 
of c-Myc. This binding interaction requires an extended region 
of c-Myc (residues 1-100) that includes the site of phosphoryl- 
ation by ERK. Together, these data indicate that ERK, like 
JNK, can bind to substrates. This binding interaction provides 
a mechanism that may contribute to the substrate specificity of 
ERK and JNK MAP kinase isoforms. 
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2.1. Materials 
[32p]Phosphate was purchased from DuPont-NEN. [y-32p]ATP was 
prepared using a Gamma-Prep A kit (Promega Biotech) as described 
by the manufacturer. Thrombin was purchased from Sigma Chemical 
Co. Polyvinylidene difluoride membranes (lmmobilon-P) were ob- 
tained from MiUipore Corp. Purified p34~/cyclin B was obtained from 
Upstate Bioteehnology Inc. Human ERK2 was purified from phorbol 
ester-treated cells as described [8,16]. Recombinant GST-fusion pro- 
teins were prepared by bacterial expression and glutathione agarose 
(Sigma Chemical Co.) affinity chromatography [17]. The recombinant 
c-Myc (residues 1-143) was purified after thrombin cleavage of GST- 
Myc [18]. 
2.2. Tissue culture 
CHO cells were maintained in Ham's F12 medium supplemented 
with 5% (v/v) fetal bovine serum (Gibco-BRL). COS-1 cells were main- 
tained in Dulbecco's modified Eagle's medium supplemented with 5% 
(v/v) fetal bovine serum (Gibco-BRL). Transient transfection of COS-1 
cells was performed using 2 gg of plasmid DNA [19]. 
2.3. Plasmids 
The plasmids encoding GST-fusion proteins with c-Myc residues 
1-439 and 98--439 [20], residues 1-262 [7], and derivatives of residues 
1-204 [21] have been described. Other GST-Myc constructs were pre- 
pared by sub-cloning PCR fragments of the c-Myc gene into the vector 
pGEX-3X (Pharmacia-LKB iotechnology Inc.). The structure of the 
plasmids constructed was confirmed by dideoxy sequencing. The plas- 
raids encoding GST fusion proteins with c-Jun residues 1-79 [5], Rb 
residues 379-928 [22], EGF-R residues 647-688 [23] have been de- 
scribed. The GST-GAP-SH2 consists of residues 178-277 of human 
GAP cloned into pGEX-2T [24]. The human ERK2 expression vector 
pCMV-p41 "~# and pCMV-(Ala-54/55)p41 m~k were described previ- 
ously [16,19]. 
2.4. In vitro protein kinase assays 
Phosphorylation assays were performed in 50/zl of kinase buffer 
(10 mM MgC12, 25 mM HEPES (pH 7.4) with 50/tM [7'-32p]ATP 
(10/zCi/nmol). The phosphorylation reactions were terminated by the 
addition of Laemmli sample buffer. The phosphorylated proteins were 
resolved by SDS-PAGE and visualized by autoradiography. In-situ 
protein kinase assays using the substrate polymerized into the gel 
were performed after SDS-PAGE by renaturation a d incubation with 
[7'-32p]ATP as described [25]. 
2.5. Binding assays 
Cells were lysed in binding buffer (1 mM EDTA, 0.1% Nonidet P-40, 
150 mM KCI, 25 mM fl-glycerophosphate, 1 mM Na-orthovanadate, 
lOIzg/ml leupeptin, 1mM PMSF, 25 mM HEPES pH 7.4) and a soluble 
extract was prepared by centrifugation i a microfuge for 30 min at 
4°C. The cell extract (200/zg) was then incubated with recombinant 
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Fig. 1. Identification of a protein kinase activity that binds to c-Myc. Cell lysates (A) or purified ERK2 (B) were incubated with GST or GST-Myc 
(residues 1-143) pre-bound to glutathione-agarose. Theagarose was incubated for 90 min at 4°C and then washed extensively. The agarose beads 
were resuspended in kinase buffer with [7-32P]ATP and incubated for 10 min at 22"C. The phosphorylation reaction was terminated by the addition 
of Laemmli sample buffer. The phosphorylated proteins were examined by SDS-PAGE and autoradiography. 
GST fusion proteins (30/tg) pre-bound to 40/zl of GSH-agarose in 
0.5 ml binding buffer. After incubation for 90 min at 4°C, the agarose 
beads were washed extensively with binding buffer. The bound proteins 
were eluted with Laemmli sample buffer. 
2.6. Western blot analysis 
Proteins resolved by SDS-PAGE were electrophoreticaUy transferred 
to polyvinylidene difluoride membranes (Immibilon-P) and analyzed by 
Western blotting. The membranes were probed with a monoclonal 
anti-ERK2 antibody (Zymed Inc.) or a monoclonal nti-p34 ~ anti- 
body (Transduction Laboratories Inc.). Immune complexes were visu- 
alized using the enhanced chemiluminescence procedure (Amersham 
International PLC). 
3.  Resu l ts  
3.1. Association of protein kinase activity with the transcription 
factor c-Myc 
The binding of protein kinases was investigated by incuba- 
tion of c-Myc with extracts prepared from cultured cells. The 
immobilized c-Myc was washed extensively and the bound pro- 
tein kinases were detected by addition of [7:2p]ATP. These 
experiments demonstrated that one or more protein kinases 
bind to c-Myc (Fig. 1A). We investigated the bound protein 
kinases by SDS-PAGE using an in-gel protein kinase assay with 
the substrate (c-Myc) polymerized in the gel. The major activity 
detected corresponded to a 42-kDa protein kinase (data not 
shown). In previous studies, we have demonstrated that the 
42-kDa protein kinase ERK2 phosphorylates c-Myc within the 
NHz-terminal activation domain at Ser-62 [7]. We therefore 
tested the hypothesis that ERK2 may account, in part, for the 
protein kinase activity present in cell extracts that binds to 
c-Myc. It was observed that purified ERK2 bound to immobi- 
lized c-Myc (Fig. 1B). Together, these data demonstrate hat 
the MAP kinase ERK2 binds and phosphorylates the transcrip- 
tion factor c-Myc. 
3.2. ERK2 forms a complex with c-Myc 
To establish the specificity of the interaction between ERK2 
and c-Myc, we examined whether ERK2 binds to other pro- 
teins. Recombinant GST-fusion proteins corresponding to 
both substrates and non-substrates were prepared (Fig. 2A). 
These proteins were incubated with purified ERK2 and 
[yJZP]ATP. GST-Myc [7], GST-EGFR [25] and GST-Jun [7] 
were phosphorylated byERK2 (Fig. 2B). However, GST, GST- 
Rb, and GST-GAP-SH2 were not detectably phosphorylated 
(Fig. 2B). The binding of ERK2 was examined by incubation 
of each GST-fusion protein with cell extracts. The complexes 
were collected on GSH-agarose beads and washed extensively. 
ERK2 bound to the GST fusion proteins was detected by West- 
ern blot analysis. Fig. 2C demonstrates that the binding of 
ERK2 was only observed in experiments using GST-Myc. This 
observation demonstrates that c-Myc associates with ERK2. 
Previous studies have demonstrated that c-Myc is 
phosphorylated in vitro at Ser-62 by p34 ca~2 [26,27]. The phos- 
phorylation of the same site by p34 cd~2 and ERK2 suggests that 
p34 *d*2, like ERK2, may bind to c-Myc. To examine this possi- 
ble interaction, we incubated cell lysates with immobilized 
c-Myc, and detected the bound kinase by Western blot analysis. 
Fig. 3 shows that p34 cd~2 binding to c-Myc was not detected. 
Together, these data provide evidence for a specific binding 
interaction between c-Myc and ERK2. 
3.3. ERK2 binds to the NH:terminal activation domain of 
c-Myc 
To define the site of interaction of ERK2 with c-Myc, we 
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Fig. 2. Demonstration of complex formation between ERK2 and 
c-Myc. (A) Purified GST-fusion proteins were resolved by SDS-PAGE 
and stained with Coomassie blue. The protein standards are 106, 80, 
49.5, 32.5 and 27.5 kDa. (B) The GST-fusion proteins were incubated 
with purified ERK2 and [7-3ZP]ATP for 10 rain at 22"C. The 
phosphorylated proteins were resolved by SDS-PAGE and detected by 
autoradiography. ((2)The binding of ERK2 to the GST-fusion proteins 
was examined. Cell extracts were incubated with GST-fusion proteins 
pre-bound to glutathione-agarose. After incubation for 90 rain at 4 ° C, 
the agarose was washed extensively. The bound fraction was subjected 
to Western blot analysis with an anti-ERK2 monoclonal antibody. 
Binding of ERK2 to GST-Myc (residues 1-143) was observed. How- 
ever, no binding of ERK2 to GST, GST-Rb, GST-EGFR, GST-GAP- 
SH2, or GST-Jun was detected. 
prepared a series of recombinant proteins consisting of differ- 
ent domains of c-Myc. Fig. 4 shows that ERK2 binds to the 
full-length c-Myc protein and to NH2-terminal fragments of 
c-Myc. Deletion analysis demonstrates that c-Myc residues 
1-100 were required and sufficient for binding to ERK2. This 
region contains the site of c-Myc phosphorylation by ERK2 
(Ser-62). 
3.4. ATP disrupts the c-MyclERK2 complex 
We investigated the role of ERK2 protein kinase activity in 
the binding interaction with c-Myc. It was found that ERK2 
activation resulted in no significant change in binding to c-Myc 
(Fig. 5). This observation suggests that ERK2 protein kinase 
activity is not required for interaction with c-Myc. To test this 
hypothesis, we investigated the properties of a catalytically 
inactive mutated ERK2 (LysWLys 55 replaced with Ala54/Ala55). 
Fig. 5 shows that there was no marked difference in binding to 
c-Myc in experiments u ing wild-type and catalytically inactive 
forms of ERK2. 
To further examine the role of ERK2 catalytic activity, we 
investigated the effect of substrate phosphorylation  ERK2 
binding to c-Myc. We incubated immobilized GST-Myc bound 
to ERK2 in the presence and absence of ATE Fig. 6 shows that 
bound ERK2 dissociates slowly from the complex with c-Myc. 
However, addition of ATP resulted in the dissociation of 
ERK2. 
4. Discussion 
It has been established that there is a critical role for protein- 
protein interactions in MAP kinase signal transduction path- 
ways. For example, in the yeast Saecharomyces cerevisiae, ge- 
netic and biochemical studies have demonstrated that the MAP 
kinase Fus3 is activated within a protein complex consisting of 
the Ste5 protein bound to the MAPKK Ste7 and the 
MAPKKK Stel 1 [28]. An Ste5-1ike protein has not been iden- 
tified in mammalian cells. However, additional protein-protein 
interactions in the mammalian MAP kinase pathway have been 
described. Thus, the MAPKKK c-Raf-1 functions as a large 
p34cdc2 
Fig. 3. c-Myc does not bind to the p34 ~ protein kinase. CHO cells 
were arrested in mitosis using nocodazole. The cells were lyzed in 
binding buffer and a soluble xtract was prepared by centrifugation at 
100,000 × g for 15 rain. The extract was incubated for 90 min at 4°C 
with GST or GST-Myc (residues 1-143) pre-bound to glutathione- 
agarose. The agarose was washed extensively and the bound proteins 
were analysed by immunoblotting with a monoclonal nti-p34 c~2 anti- 
body. The antibody specificity was confirmed by immunoblot analysis 
of the cell lysate and purified p34C~2/cyclin B. 
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Fig. 4. ERK2 binds to an NH2-terminal region of the c-Myc transactivation domain. The binding of ERK2 to a panel of GST-Myc fusion proteins 
was examined. Cell extracts were incubated with GST and GST-fusion proteins pre-bound to glutathione agarose. After incubation for 90 min at 
4°C, the agarose was washed extensively and the bound fraction was subjected to Western blot analysis with an anti-ERK2 monocional antibody. 
The region required for binding to ERK2 was identified as the c-Myc NH2-terminus (residues 1-100). 
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Fig. 5. Enzymatically active and inactive forms of ERK2 bind to c-Myc. COS ceils were mock-transfected or transfected with an ERK2 expression 
vector. The COS cells were serum-starved for 18 h and activated with 10% (v/v) fetal calf serum for 30 rain. The cells were then harvested and soluble 
extracts were prepared. These extracts were incubated with GST and GST-Myc (residues 1-143) pre-bound to glutathione-agarose. After incubation 
for 90 rain at 4°C, the agarose was washed extensively and the bound fraction was subjected to Western blot analysis with an anti-ERK2 monoclonai 
antibody. 
membrane-bound complex [29] that associates with Ras and the 
MAPKK Mek [29-34]. Protein-protein interactions have also 
been implicated inthe mechanism ofsubstrate phosphorylation 
by the JNK group of MAP kinases [2,5,6]. In contrast, a role 
TPA 
- + + + 
for protein-protein i teractions in the substrate specificity of 
the ERK group of MAP kinases has not been established. 
Substrate recognition by ERK is dependent on the primary 
sequence surrounding the site of phosphorylation [4,7-9]. Al- 
though the optimal motif is Pro-Xaa-Ser/Thr-Pro, the minimal 
primary sequence r quired for phosphorylation is Ser/Thr-Pro 
[4]. This primary sequence motif (Ser/Thr-Pro) is, however, 
insufficient o account for the high level of ERK substrate 
specificity [4]. Substrate selection may therefore be guided by 
properties of the substrate inaddition to the primary sequence 
at the site of phosphorylation. Substrate binding represents one 
- 4 -  
ATP 
c-Myc 
<.... 
Fig. 6. The ERK2 complex with c-Myc is disrupted by ATE COS cells 
were transfected with an ERK2 expression vector. The cells were 
treated with and without 100 nM TPA for 30 rain prior to harvesting. 
The soluble extracts obtained were incubated with GST-Myc (residues 
1-143) pre-bound to glutathione-agarose. After incubation for 90 rain 
at 4°C, the agarose was washed extensively. The bound proteins were 
eluted at 22°C for 20 rain using kinase buffer supplemented with and 
without 50/aM ATP. The ERK2 activity bound to the column prior to 
elution (left) and in the eluate (right) was measured using the c-Myc 
NH2-terminal domain and [F-32P]ATP as substrates. The c-Myc NH2- 
terminal domain substrate was prepared by purification of the c-Myc 
fragment obtained afte# thrombin cleavage of GST-Myc (residues 
1-143). 
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mechanism that may contribute to the specificity of substrate 
phosphorylation by ERK. 
In this report we describe the binding of ERK to the sub- 
strate c-Myc. Previous studies have described the functional 
interaction of c-Myc with several proteins, including Max 
[35,36], the p107 Rb-related protein [37], TFI I - I  [38], and the 
TATA-binding protein [39,40]. Complex formation with ERK 
therefore represents an additional interaction mediated by 
c-Myc. 
The binding interaction with c-Myc does not require ERK2 
protein kinase activity. However, the formation of the c-Myc/ 
ERK2 complex is disrupted by ATE This effect of ATP sug- 
gests that the c-Myc/ERK2 complex represents an intermediate 
in the phosphorylation reaction rather than a non-productive 
enzyme/substrate complex. This binding interaction therefore 
provides a mechanism that may contribute to the specificity of 
substrate phosphorylation by ERK. 
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